Obsidian Therapeutics, Inc.
OBX
$17.77
-$1.15-6.08%
NASDAQ
| 03/31/2026 | |||||
|---|---|---|---|---|---|
| Net Income | 21.42% | ||||
| Total Depreciation and Amortization | -10.05% | ||||
| Total Amortization of Deferred Charges | -- | ||||
| Total Other Non-Cash Items | -5.48% | ||||
| Change in Net Operating Assets | -299.90% | ||||
| Cash from Operations | 9.66% | ||||
| Capital Expenditure | -- | ||||
| Sale of Property, Plant, and Equipment | -- | ||||
| Cash Acquisitions | -- | ||||
| Divestitures | -- | ||||
| Other Investing Activities | -40.99% | ||||
| Cash from Investing | -40.75% | ||||
| Total Debt Issued | -- | ||||
| Total Debt Repaid | -- | ||||
| Issuance of Common Stock | 683.33% | ||||
| Repurchase of Common Stock | -- | ||||
| Issuance of Preferred Stock | -- | ||||
| Repurchase of Preferred Stock | -- | ||||
| Total Dividends Paid | -- | ||||
| Other Financing Activities | -- | ||||
| Cash from Financing | 683.33% | ||||
| Foreign Exchange rate Adjustments | -- | ||||
| Miscellaneous Cash Flow Adjustments | -- | ||||
| Net Change in Cash | -28.60% | ||||